Unique ID issued by UMIN | UMIN000049996 |
---|---|
Receipt number | R000056942 |
Scientific Title | Evaluate hair growth effect by long-term use of study sample |
Date of disclosure of the study information | 2023/01/10 |
Last modified on | 2023/07/12 14:17:21 |
Hair growth trial
Hair growth trial
Evaluate hair growth effect by long-term use of study sample
Hair growth trial
Japan |
Healthy adult
Adult |
Others
NO
Evaluate the hair growth effect of the study sample in healthy adult women who are worried about thinning hair in an 18-week repeated dose topical administration study.
Safety,Efficacy
Photo Trichogram (Hair number, Hair growth rate, Hair diameter, Anagen hair percentage)
Photography of area at top of head and investigation of adverse event
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Other |
The study sample is applied twice daily to the scalp in prescribed amounts for 18 weeks.
Placebo is applied twice daily to the scalp in prescribed amounts for 18 weeks.
40 | years-old | <= |
69 | years-old | >= |
Female
1. Healthy Japanese females aged 40 to 69 at the time of informed consent
2. Subjects who is worried about thinning hair and hair loss
3. Subjects who agree to keep the conditions such as hair conditioning and hair dyeing constant on each visiting day
4. Subjects who agree to cut hair locally approximately 1.0 cm x 1.0 cm near the crown on each visiting day
5. Subjects who have signed a consent at own discretion before the start of the study
1. Subjects with pathological hair loss such as alopecia areata
2. Subjects with scalp diseases other than hair loss (eg, head eczema, seborrheic eczema, psoriasis, tinea capitis, and other scalp infections)
3. Subjects who regularly apply external application or take oral medicines, supplements, etc. that may affect the condition of the head
4. Subjects with a history of hypersensitivity (allergies) to hair growth agents, hair restorer, cosmetics (shampoo, etc.), or hypersensitivity to other medicines.
5. Subjects who have used existing hair growth agents and hair restorer within the past 2 months, regardless of whether they are pharmaceutical products or quasi-drugs.
6. Subjects who regularly use wigs during the study period, subjects who have undergone hair transplantation or hair growth, or subjects who are scheduled during the study period
7. Subjects currently using medications known to cause trichotillomania or hirsutism (eg, phenytoin for epilepsy)
8. Subjects undergoing hormone replacement therapy or taking oral contraceptives
9. Subjects who are pregnant or lactating, or who intend to become pregnant
10. Subjects who have participated in another clinical study within the past month or those who plan to participate during the study period
11. Subjects judged inappropriate for this study
20
1st name | Manabu |
Middle name | |
Last name | Sawamoto |
Shukugawa Sawamoto Hifuka
Shukugawa Sawamoto Hifuka
662-0977
11-3, Kagura-cho, Nishinomiya City, Hyogo, Japan
0798-37-1112
sawamoto0908@yahoo.co.jp
1st name | Ayaka |
Middle name | |
Last name | Taniguchi |
R&D Center, Nikko Chemicals Co., Ltd.
under constraction
541-0052
1-6-14 Azuchimachi,Chuo-ku,Osaka City, Osaka, Japan
080-4249-0198
volunteer@nikkolgroup.com
Nikoderm Research Inc.
Tsuno Rice Fine Chemicals Co., Ltd.
Profit organization
under constraction
1-6-14 Azuchimachi,Chuo-ku,Osaka City, Osaka, Japan
06-6125-3501
myamamura@nikkolgroup.com
NO
2023 | Year | 01 | Month | 10 | Day |
Unpublished
Completed
2023 | Year | 01 | Month | 10 | Day |
2023 | Year | 01 | Month | 24 | Day |
2023 | Year | 01 | Month | 31 | Day |
2023 | Year | 09 | Month | 30 | Day |
2023 | Year | 01 | Month | 09 | Day |
2023 | Year | 07 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056942